These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 20506947)

  • 41. Mutant p53 expression and DNA analysis in human breast cancer comparison with conventional clinicopathological parameters.
    Rosanelli GP; Steindorfer P; Wirnsberger GH; Klimpfinger M; Ratschek M; Puerstner P; Auner H; Berhold A
    Anticancer Res; 1995; 15(2):581-6. PubMed ID: 7763041
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Giant cell tumor of bonelike lesion in a Trp53 mutant mouse.
    Radaelli E; Rustighi A; Scanziani E
    Toxicol Pathol; 2012 Jun; 40(4):675-81. PubMed ID: 22328409
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Factors related to biologic behavior in giant cell tumor of bone].
    Ran XY; Huang J; Zhang HZ; Jiang ZM; Chen J
    Zhonghua Bing Li Xue Za Zhi; 2013 Oct; 42(10):669-74. PubMed ID: 24433729
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A case of secondary malignant giant-cell tumor of bone with p53 mutation after long-term follow-up.
    Saito T; Mitomi H; Izumi H; Suehara Y; Okubo T; Torigoe T; Takagi T; Kaneko K; Sato K; Matsumoto T; Yao T
    Hum Pathol; 2011 May; 42(5):727-33. PubMed ID: 21237496
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Histological and clinical characteristics of malignant giant cell tumor of bone.
    Gong L; Liu W; Sun X; Sajdik C; Tian X; Niu X; Huang X
    Virchows Arch; 2012 Mar; 460(3):327-34. PubMed ID: 22350004
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prognostic value of p53 protein expression in giant cell tumor of bone.
    Yalcinkaya U; Ugras N; Kabul S; Ocakoglu G; Bilgen MS
    Pol J Pathol; 2015 Dec; 66(4):389-96. PubMed ID: 27003771
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Identification of differentially expressed genes and their subpathways in recurrent versus primary bone giant cell tumors.
    Chen S; Li C; Wu B; Zhang C; Liu C; Lin X; Wu X; Sun L; Liu C; Chen B; Zhong Z; Xu L; Li E
    Int J Oncol; 2014 Sep; 45(3):1133-42. PubMed ID: 24969034
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cytofluorometric DNA ploidy analysis in giant cell tumor of bone: histologic and prognostic value.
    Murata H; Kusuzaki K; Takeshita H; Hirata M; Hashiguchi S; Ashihara T; Hirasawa Y
    Cancer Lett; 1999 Mar; 136(2):223-9. PubMed ID: 10355752
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Histological and immunohistochemical features and genetic alterations in the malignant progression of giant cell tumor of bone: a possible association with TP53 mutation and loss of H3K27 trimethylation.
    Ishihara S; Yamamoto H; Iwasaki T; Toda Y; Yamamoto T; Yoshimoto M; Ito Y; Susuki Y; Kawaguchi K; Kinoshita I; Yamada Y; Kohashi K; Fujiwara T; Setsu N; Endo M; Matsumoto Y; Kakuda Y; Nakashima Y; Oda Y
    Mod Pathol; 2022 May; 35(5):640-648. PubMed ID: 34785767
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Gene expression profiling identifies p63 as a diagnostic marker for giant cell tumor of the bone.
    Lee CH; Espinosa I; Jensen KC; Subramanian S; Zhu SX; Varma S; Montgomery KD; Nielsen TO; van de Rijn M; West RB
    Mod Pathol; 2008 May; 21(5):531-9. PubMed ID: 18192965
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Giant cell tumor of bone: a clinicopathologic study of prognostic factors.
    Masui F; Ushigome S; Fujii K
    Pathol Int; 1998 Sep; 48(9):723-9. PubMed ID: 9778111
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prognostic role of nuclear factor/IB and bone remodeling proteins in metastatic giant cell tumor of bone: A retrospective study.
    Quattrini I; Pollino S; Pazzaglia L; Conti A; Novello C; Ferrari C; Pignotti E; Picci P; Benassi MS
    J Orthop Res; 2015 Aug; 33(8):1205-11. PubMed ID: 25764026
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Expression of Matrix Metalloproteinase-9 and CD34 in Giant Cell Tumor of Bone.
    Zhou X; Liu XZ; Fan GT; Wu SJ; Zhao JN; Shi X
    Orthop Surg; 2016 May; 8(2):220-5. PubMed ID: 27384731
    [TBL] [Abstract][Full Text] [Related]  

  • 54. H3F3A mutation as a marker of malignant giant cell tumor of the bone: A case report and review of literature.
    Ratnagiri R; Uppin S
    J Cancer Res Ther; 2023; 19(3):832-834. PubMed ID: 37470622
    [TBL] [Abstract][Full Text] [Related]  

  • 55. p53 mutations may be involved in malignant transformation of giant cell tumor of bone through interaction with GPX1.
    Okubo T; Saito T; Mitomi H; Takagi T; Torigoe T; Suehara Y; Kaneko K; Yao T
    Virchows Arch; 2013 Jul; 463(1):67-77. PubMed ID: 23748877
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Absence of H3F3A mutation in a subset of malignant giant cell tumor of bone.
    Yoshida KI; Nakano Y; Honda-Kitahara M; Wakai S; Motoi T; Ogura K; Sano N; Shibata T; Okuma T; Iwata S; Kawai A; Ichimura K; Yoshida A
    Mod Pathol; 2019 Dec; 32(12):1751-1761. PubMed ID: 31285528
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Secondary malignant giant-cell tumour of bone: molecular abnormalities of p53 and H-ras gene correlated with malignant transformation.
    Oda Y; Sakamoto A; Saito T; Matsuda S; Tanaka K; Iwamoto Y; Tsuneyoshi M
    Histopathology; 2001 Dec; 39(6):629-37. PubMed ID: 11903582
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Malignant Giant Cell Tumor of Bone With a KRAS G12V Mutation.
    Donigian S; Whiteway SL; Hipp SJ; Lybeck D; Clark RO
    J Pediatr Hematol Oncol; 2022 Jan; 44(1):e268-e271. PubMed ID: 33633024
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The highly prevalent H3F3A mutation in giant cell tumours of bone is not shared by sporadic central giant cell lesion of the jaws.
    Gomes CC; Diniz MG; Amaral FR; Antonini Guimarães BV; Gomez RS
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2014 Nov; 118(5):583-5. PubMed ID: 25442495
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [H3F3A mutated multicentric giant cell tumor of bone : A very rare primary bone disease].
    Giesche JP; von Baer A; Breining T; Marienfeld R; Mellert K; Lüke J; Schultheiss M; Möller P; Barth TFE
    Pathologe; 2018 Sep; 39(5):451-456. PubMed ID: 30046846
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.